CXCR3 antagonists
    6.
    发明授权
    CXCR3 antagonists 有权
    CXCR3拮抗剂

    公开(公告)号:US06794379B2

    公开(公告)日:2004-09-21

    申请号:US10164690

    申请日:2002-06-06

    IPC分类号: A61K3133

    摘要: Compounds, compositions and methods that are useful in the treatment of inflammatory and immune conditions and diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of a chemokine receptor. The subject methods are useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes.

    摘要翻译: 本文提供了可用于治疗炎症和免疫疾病和疾病的化合物,组合物和方法。 特别地,本发明提供调节趋化因子受体的表达和/或功能的化合物。 本发明的方法可用于治疗炎性和免疫调节性疾病和疾病,例如多发性硬化,类风湿性关节炎和I型糖尿病。

    2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity
    10.
    发明授权
    2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity 失效
    具有抗细胞增殖活性的2,4-二氨基嘧啶脱除物

    公开(公告)号:US06716831B1

    公开(公告)日:2004-04-06

    申请号:US09914788

    申请日:2001-11-15

    IPC分类号: A61K3133

    CPC分类号: C07D403/04

    摘要: A pyrimidine derivative of formula (I) or (I′): wherein: Rx is a substituent as defined within; Q1 is optionally substituted phenyl, and Q1 bears a substituent of formula (Ia) wherein: X, Y1, Y2, Z, n, and m are as defined within; —NQ2 is an optionally substituted heterocyclic moiety containing one hydrogen heteroatom and optionally containing a further heteroatom; or a pharmaceutically acceptable salt in vivo hydrolysable ester thereof; are useful as anti-cancer agents. Processes for their manufacture and pharmaceutical compositions containing them are described.

    摘要翻译: 式(I)或(I')的嘧啶衍生物:其中:R x是如下定义的取代基; Q1是任选取代的苯基,并且Q1具有式(Ia)的取代基,其中:X,Y 1,Y 2,Z,n和m如在其中所定义; -NQ2是含有一个氢原子并任选地含有另外的杂原子的任选取代的杂环部分; 或其药学上可接受的盐的体内可水解的酯; 可用作抗癌剂。 描述了其制备方法和含有它们的药物组合物。